Stage Two 2024: Double Success for aisencia®!

On October 30–31, 2024, Berlin became the epicenter of Europe’s startup scene as the final round of the prestigious Stage Two competition brought together the continent’s most innovative early-stage ventures. Only 48 startups from across Europe made it to the final event in Berlin – including aisencia®, which once again showcased its groundbreaking potential.

At the heart of our presentation was Daniel Otero, who delivered an impressive pitch highlighting the latest advancements in Vistaneos. This cutting-edge laboratory software is specifically designed to support pathologists, offering them new levels of efficiency and precision in their daily work. Our vision and commitment did not go unnoticed: aisencia® achieved double recognition! Both b2venture and xdeck were highly impressed, awarding us investment options of €500,000 each. This milestone underscores not only the transformative value of Vistaneos in medical imaging but also aisencia’s potential to redefine the future of pathology. We are proud of this achievement and look forward to growing further with new partners as we bring our vision to life!

Similar Posts